Benoı̂t J. Van den Eynde
Ludwig Cancer Research(BE)Nuffield Orthopaedic Centre(GB)University of Oxford(GB)Ludwig Cancer Research(GB)Immunité et Cancer(FR)de Duve Institute(BE)Walloon Excellence in Lifesciences and Biotechnology(BE)UCLouvain(BE)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Tryptophan and brain disorders, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, CAR-T cell therapy research
Most-Cited Works
- → Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase(2003)2,279 cited
- → Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy(2014)1,106 cited
- → Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion(2012)692 cited
- → HUMAN T CELL RESPONSES AGAINST MELANOMA(2005)651 cited
- → T cell defined tumor antigens(1997)624 cited
- → Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase(2012)566 cited